Summary

Analytical Instrumentation Market Summary

The global analytical instrumentation market size was estimated at USD 55.00 billion in 2024 and is anticipated to reach USD 90.48 billion by 2033, growing at a CAGR of 5.79% from 2025 to 2033. Rising requirements for accurate quality assurance, ongoing innovations in research and development, stricter regulatory standards, and broader usage across sectors such as pharmaceuticals, environmental monitoring, food safety, and chemicals primarily fuel the market expansion.

Global Analytical Instrumentation Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global analytical instrumentation market report on the basis of product, technology, application, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Services
• Software
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Polymerase Chain Reaction
• Spectroscopy
• Microscopy
• Chromatography
• Flow Cytometry
• Sequencing
• Microarray
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Life Sciences Research & Development
• Clinical & Diagnostic Analysis
• Food & Beverage Analysis
• Forensic Analysis
• Environmental Testing
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.3. Information Analysis
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing
1.6. Research Assumptions
1.7. Information Procurement
1.7.1. Primary Research
1.8. Information or Data Analysis
1.9. Market Formulation & Validation
1.10. Market Model
1.11. Global Market: CAGR Calculation
1.12. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological advancements in analytical instruments
3.2.1.2. Increasing R&D spending by pharmaceutical industry & government research organizations
3.2.1.3. Increasing adoption of analytical instrumentation for precision medicine applications
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of instruments
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Analytical Instrumentation Market Product Movement Analysis
4.3. Analytical Instrumentation Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments Market
4.5. Services
4.5.1. Services Market
4.6. Software
4.6.1. Software Market
Chapter 5. Technology Business Analysis
5.1. Technology Segment Dashboard
5.2. Analytical Instrumentation Market Technology Movement Analysis
5.3. Analytical Instrumentation Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. Polymerase Chain Reaction
5.4.1. Polymerase Chain Reaction Market
5.5. Spectroscopy
5.5.1. Spectroscopy Market
5.6. Microscopy
5.6.1. Microscopy Market
5.7. Chromatography
5.7.1. Chromatography Market
5.8. Flow Cytometry
5.8.1. Flow Cytometry Market
5.9. Sequencing
5.9.1. Sequencing Market
5.10. Microarray
5.10.1. Microarray Market
5.11. Others
5.11.1. Others Market
Chapter 6. Application Business Analysis
6.1. Application Segment Dashboard
6.2. Analytical Instrumentation Market Application Movement Analysis
6.3. Analytical Instrumentation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Life Sciences Research & Development
6.4.1. Life Sciences Research & Development Market
6.5. Clinical & Diagnostic Analysis
6.5.1. Clinical & Diagnostic Analysis Market
6.6. Food & Beverage Analysis
6.6.1. Food & Beverage Analysis Market
6.7. Forensic Analysis
6.7.1. Forensic Analysis Market
6.8. Environmental Testing
6.8.1. Environmental Testing Market
6.9. Others
6.9.1. Others Market
Chapter 7. Regional Business Analysis
7.1. Analytical Instrumentation Market Share By Region, 2024 & 2033
7.2. North America
7.2.1. North America Analytical Instrumentation Market
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Target Disease Prevalence
7.2.2.4. U.S. Analytical Instrumentation Market
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Target Disease Prevalence
7.2.3.4. Canada Analytical Instrumentation Market
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Competitive Scenario
7.2.4.3. Target Disease Prevalence
7.2.4.4. Mexico Analytical Instrumentation Market
7.3. Europe
7.3.1. Europe Analytical Instrumentation Market
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Target Disease Prevalence
7.3.2.4. UK Analytical Instrumentation Market
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Target Disease Prevalence
7.3.3.4. Germany Analytical Instrumentation Market
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Target Disease Prevalence
7.3.4.4. France Analytical Instrumentation Market
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Target Disease Prevalence
7.3.5.4. Italy Analytical Instrumentation Market
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Target Disease Prevalence
7.3.6.4. Spain Analytical Instrumentation Market
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Target Disease Prevalence
7.3.7.4. Denmark Analytical Instrumentation Market
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Target Disease Prevalence
7.3.8.4. Sweden Analytical Instrumentation Market
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Target Disease Prevalence
7.3.9.4. Norway Analytical Instrumentation Market
7.4. Asia Pacific
7.4.1. Asia Pacific Analytical Instrumentation Market
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Target Disease Prevalence
7.4.2.4. Japan Analytical Instrumentation Market
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Target Disease Prevalence
7.4.3.4. China Analytical Instrumentation Market
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Target Disease Prevalence
7.4.4.4. India Analytical Instrumentation Market
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Target Disease Prevalence
7.4.5.4. Australia Analytical Instrumentation Market
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Target Disease Prevalence
7.4.6.4. Thailand Analytical Instrumentation Market
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Target Disease Prevalence
7.4.7.4. South Korea Analytical Instrumentation Market
7.5. Latin America
7.5.1. Latin America Analytical Instrumentation Market
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Target Disease Prevalence
7.5.2.4. Brazil Analytical Instrumentation Market
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Target Disease Prevalence
7.5.3.4. Argentina Analytical Instrumentation Market
7.6. MEA
7.6.1. MEA Analytical Instrumentation Market
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Target Disease Prevalence
7.6.2.4. South Africa Analytical Instrumentation Market
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Target Disease Prevalence
7.6.3.4. Saudi Arabia Analytical Instrumentation Market
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Target Disease Prevalence
7.6.4.4. UAE Analytical Instrumentation Market
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Target Disease Prevalence
7.6.5.4. Kuwait Analytical Instrumentation Market
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Water Corporation
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Shimadzu Corporation
8.4.3.1. Overview F
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Danaher
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Agilent Technologies, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Bruker
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. PerkinElmer Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. METTLER TOLEDO
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Zeiss Group
8.4.9.1. Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. Bio-Rad Laboratories, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Illumina, Inc.
8.4.11.1. Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Eppendorf SE
8.4.12.1. Overview
8.4.12.2. Product Benchmarking
8.4.12.3. Strategic Initiatives
8.4.13. F. Hoffmann- La Roche Ltd
8.4.13.1. Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Sartorius AG
8.4.14.1. Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives
8.4.15. Avantor, Inc.
8.4.15.1. Overview
8.4.15.2. Financial Performance
8.4.15.3. Product Benchmarking
8.4.15.4. Strategic Initiatives